MedPath

Multilevel Intervention Based on Colorectal Cancer (CRC) and Cervical Cancer Self-screening in Rural, Segregated Areas

Not Applicable
Completed
Conditions
Colorectal Cancer Screening
Cervical Cancer Screening
Interventions
Diagnostic Test: Self-sampling HPV test
Diagnostic Test: Fecal occult blood test
Registration Number
NCT04471194
Lead Sponsor
Milton S. Hershey Medical Center
Brief Summary

In this study, the investigators will deliver self-sampling human papillomavirus (HPV) tests and fecal immunochemical test (FIT) kits, as well as adapted cancer screening educational materials, by mail to 110 women who are out-of-date for both cervical and colorectal cancer screenings, recruited through federally qualified health centers (FQHCs) in rural, segregated counties of Pennsylvania.

The hypothesis is that delivering self-sampling HPV tests and FIT, as well as adapted educational materials, to women in rural, segregated areas could help increase cancer screening, reduce geographic cancer disparities, and improve public health.

Detailed Description

In this study, the investigators will deliver self-sampling human papillomavirus (HPV) tests and fecal immunochemical test (FIT) kits, as well as adapted cancer screening educational materials, by mail to 110 women who are out-of-date for both cervical and colorectal cancer screenings, recruited through federally qualified health centers (FQHCs) in rural, segregated counties of Pennsylvania. A control group of 110 women, also recruited through FQHCs in rural, segregated counties of Pennsylvania, will be used for comparison; these women will receive standard-of-care reminders for cancer screening and complete the baseline and follow-up surveys.

The hypothesis is that delivering self-sampling HPV tests and FIT, as well as adapted educational materials, to women in rural, segregated areas could help increase cancer screening, reduce geographic cancer disparities, and improve public health.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
48
Inclusion Criteria
  • lives in rural, segregated county of Pennsylvania
  • able to speak, read, and communicate well in English
  • out of date for both cervical and colorectal cancer screening
Exclusion Criteria
  • has had a partial or complete hysterectomy
  • has a family history of colorectal cancer
  • has a personal history of cervical or colorectal cancer
  • persons who are cognitively impaired
  • persons who are incarcerated

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Self-Sampling InterventionSelf-sampling HPV testParticipants in this group will receive cervical and colorectal cancer self-sampling kits, instructions for completing the self-sampling kits, and educational materials about cervical and colorectal cancer.
Self-Sampling InterventionFecal occult blood testParticipants in this group will receive cervical and colorectal cancer self-sampling kits, instructions for completing the self-sampling kits, and educational materials about cervical and colorectal cancer.
Primary Outcome Measures
NameTimeMethod
Difference in Percentage of Participants Who Completed Any Cervical PLUS Colorectal Cancer Screening Tests10 weeks

Difference in percentage of participants who self-report having had cervical cancer screening PLUS having had colorectal cancer screening (all modalities) by the end of the study period between the two arms.

Secondary Outcome Measures
NameTimeMethod
Difference in Percentage of Participants Who Completed At-home Cervical PLUS Colorectal Cancer Screening Tests10 weeks

Difference in percentage of participants who completed at-home cervical cancer screening test PLUS completed at-home colorectal cancer screening test by the end of the study period between the two arms.

Trial Locations

Locations (1)

Penn State College of Medicine

🇺🇸

Hershey, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath